Literature DB >> 1824262

c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35).

T J Fitzgerald1, G A Neale, S C Raimondi, R M Goorha.   

Abstract

Studies on nonrandom chromosomal translocations have been important for the identification of genes potentially involved in the malignant transformation of cells. The most widely studied translocations, involving members of the Ig supergene family, have shown juxtapositions of proto-oncogenes with the rearranging loci. Such translocations can inappropriately activate expression of the proto-oncogenes and thereby play a role in tumorigenesis. Because the cytogenetic analysis of a bone marrow sample from a child with T-cell acute lymphoblastic leukemia showed a (1;7)(p32;q35) translocation, we sought to determine if the translocation breakpoint was in the T-cell receptor (TCR)-beta gene locus on chromosome 7. Analysis of the TCR-beta gene by Southern blotting showed three rearranged bands. Nucleotide sequencing and Southern blot analysis of TCR-beta genomic clones, isolated from patient DNA, showed that one contained a normal rearrangement of the TCR-beta gene using V beta 12.2, D beta 2.1, and J beta 2.5, whereas two other clones contained DNA from derivative chromosomes 1 and 7. Chromosomal mapping showed that the (1;7) translocation breakpoint was 35 kb 3' to the c-tal gene locus. The juxtaposition of c-tal to the TCR-beta locus may enhance c-tal expression and contribute to T-cell leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824262

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Genomic analysis of CD8+ NK/T cell line, 'SRIK-NKL', with array-based CGH (aCGH), SKY/FISH and molecular mapping.

Authors:  Michael R Rossi; Jeff Laduca; John K Cowell; Bejai I S Srivastava; Seiichi Matsui
Journal:  Leuk Res       Date:  2007-07-20       Impact factor: 3.156

2.  Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1.

Authors:  J T Cheng; M H Cobb; R Baer
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

3.  Frequency and DNA sequence of tal-1 rearrangement in children with T-cell acute lymphoblastic leukemia.

Authors:  A Borkhardt; R Repp; J Harbott; C Keller; F Berner; J Ritterbach; F Lampert
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 4.  Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia.

Authors:  Nicole S D Larmonie; Willem A Dik; Jules P P Meijerink; Irene Homminga; Jacques J M van Dongen; Anton W Langerak
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

5.  Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.

Authors:  D S Chervinsky; X F Zhao; D H Lam; M Ellsworth; K W Gross; P D Aplan
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

6.  Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?

Authors:  Matthew A Lunning; Steven Horwitz
Journal:  Curr Treat Options Oncol       Date:  2013-06

Review 7.  Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia.

Authors:  R Stasi; C G Taylor; A Venditti; G Del Poeta; G Aronica; C Bastianelli; M D Simone; F Buccisano; M C Cox; A Bruno
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673

Review 8.  Transcriptional control of blood cell emergence.

Authors:  Sara Menegatti; Marcel de Kruijf; Eva Garcia-Alegria; Georges Lacaud; Valerie Kouskoff
Journal:  FEBS Lett       Date:  2019-08-31       Impact factor: 4.124

9.  A third tal-1 promoter is specifically used in human T cell leukemias.

Authors:  O Bernard; O Azogui; N Lecointe; F Mugneret; R Berger; C J Larsen; D Mathieu-Mahul
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

10.  Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.

Authors:  Ying Li; Ziwei Liao; Huacheng Luo; Aissa Benyoucef; Yuanyuan Kang; Qian Lai; Sinisa Dovat; Barbara Miller; Iouri Chepelev; Yangqiu Li; Keji Zhao; Marjorie Brand; Suming Huang
Journal:  Nucleic Acids Res       Date:  2020-04-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.